Beste Endokrinologen in Italien - TOP -9 Ärzte

Professor Riccardo Rosati ist Leiter der Abteilung für Magen-Darm-Chirurgie (GI) am Forschungskrankenhaus San Raffaele in Mailand, Italien. Er ist ein sehr erfahrener Chirurg mit über 30 Jahren Erfahrung und hat einen Abschluss in Allgemeinmedizin und allgemeiner Chirurgie sowie eine Spezialisierung auf Thoraxchirurgie. Er ist Mitglied mehrerer chirurgischer Vereinigungen und hat über 300 Publikationen verfasst. Seine Abteilung behandelt etwa 2.000 chirurgische Fälle pro Jahr.

Dr. ist Direktor der Abteilung für endokrine und bariatrische Chirurgie und Leiter des bariatrischen Zentrums des Mater Olbia Hospital. Er hat einen Abschluss in Medizin und Chirurgie von der Medizinischen Fakultät der Università Cattolica del Sacro Cuore in Rom, Italien, und ein Zertifikat als Facharzt für Allgemeine Chirurgie von derselben Schule. Sein Hauptaugenmerk liegt auf laparoskopischen chirurgischen Ansätzen bei krankhafter Adipositas und endokrinen Erkrankungen, mit besonderem Interesse an minimal-invasiven Techniken. Er hat über 4500 chirurgische Eingriffe durchgeführt, darunter 1500 als Erstoperateur, und hat an der School of Medicine und der National School of Endocrine Surgery der Italian Society of Surgery gelehrt.

Endokrinologe

He graduated in Medicine and Surgery from the University of Padua, where, in 1996, he obtained the specialization in Endocrinology, Diabetology and Metabolic Diseases. In 1994 he specialized in Metabolic Diseases from the San Bortolo University Hospital in Vicenza. Engaged in research activities in the areas of use of engineered tissues and growth factors for tissue regeneration, new technologies in the field of conservative surgical treatment, and extreme percutaneous revascularization protocols. He has been chairman of several international courses on Diabetic Foot and Charcot Foot and he is a member of the Editorial Board of the journal "Diabetic Foot and Ankle", and of the European Diabetic Foot Study Group (DFSG).

Author of over 100 scientific publications and about 300 speeches at international congresses, including several editions of the National Congress of the Diabetes Doctors Association or the Italian Journal of Diabetology.

Awarded with "Ilizarov Award of Excellence" at the International External Fixation Symposium, 2018; -“Paul Brand Memorial Lecture” Award in 2016.

Prof. Andrea Lania has graduated at the Università degli Studi of Milan and is specialized in endocrinology. He is the Unit Director of Endocrinology and Diabetology in Humanitas Research Hospital and his specialization is pituitary diseases, pituitary adenomas, thyroid cancer, pancreatic neuroendocrine tumors, poorly differentiated neuroendocrine carcinomas.

Medical areas of interest:
Pituitary tumors, hypopituitarism, acromegaly, Cushing’s disease and syndrome, neuroendocrine tumors, thyroid and thyroid diseases, adrenal and adrenal diseases, hypogonadism.

Research areas of interest:
Study of the pathogenetic mechanisms of pituitary and neuroendocrine tumors, of the molecular mechanisms responsible for the different response of pituitary and neuroendocrine tumors to medical therapy.

Prof. Lania published 198 peer-reviewed papers (Google Scholar H-Index 47; Scopus H-Index 38, cit tot 4604)

Prof. Lania has a long standing expertise in the field of intra-cellular signaling in endocrine tumors. In particular, in the past ten years, he contributed to analyze the role of PKA regulatory subunits in the pathogenesis and control of cell proliferation of endocrine tumors. Moreover, he contributed to define the role of SSTR5 domains involved in the intracellular trafficking of this receptor in human pituitary cells and to analyze the impact of DR2R and SSTR2&5 polymorphic variants on both the clinical outcome and response to medical treatment in patients with pituitary tumors.

Recently, he contributed to identify the role of cytoskeleton protein FLNA in mediating both intracellular signaling and membrane targeting of somatostatin type 2 receptor and D2R in pituitary and pancreatic neuroendocrine tumors. Finally, he contributed to explore the intracellular mechanisms possibly involved in mediating the interplay between drugs commonly used in the treatment of neuroendocrine tumors.

Previous experience:
2005-2008 Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy
Director of Endocrinologic Day Hospital and surgery on pituitary disorders. 

Publications: https://www.ncbi.nlm.nih.gov/pubmed?term=lania%20A